Cargando…
The Design and Synthesis of a New Class of RTK/HDAC Dual-Targeted Inhibitors
Over the years, the development of targeted medicines has made significant achievements. As a typical example, receptor tyrosine kinases (RTK) inhibitors have become important chemotherapy drugs for a variety of cancers. However, the effectiveness of these agents is always hindered by poor response...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269723/ https://www.ncbi.nlm.nih.gov/pubmed/23736786 http://dx.doi.org/10.3390/molecules18066491 |